Angiotensin II Pregnancy and Breastfeeding Warnings
Brand names: Giapreza
Angiotensin II Pregnancy Warnings
The manufacturer makes no recommendation regarding use during pregnancy.
US FDA pregnancy category: Not assigned.
Risk Summary: No data available on use of this drug in pregnant women to inform a drug-related risk.
Comments: Septic or other distributive shock is a medical emergency that can be fatal if left untreated and thus delaying treatment in pregnant women with hypotension associated with septic or other distributive shock is likely to increase the risk of maternal and fetal morbidity and mortality.
Animal studies have not been reported. There are no controlled data in human pregnancy.
US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.
Angiotensin II Breastfeeding Warnings
The manufacturer makes no recommendation regarding use during lactation.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: The effects in the nursing infant are unknown.
See also
References for pregnancy information
- (2022) "Product Information. Giapreza (angiotensin II)." La Jolla Pharmaceutical
References for breastfeeding information
- (2022) "Product Information. Giapreza (angiotensin II)." La Jolla Pharmaceutical
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
